Literature DB >> 23605987

Ciprofloxacin-associated choreoathetosis in a haemodialysis patient.

Ahad Abdalla1, Shazrul Ramly, Peter Boers, Liam Casserly.   

Abstract

This report describes a case of drug-associated choreoathetosis in a patient receiving ciprofloxacin. A 72-year-old haemodialysis patient presented with a 4-day history of progressive weakness, restlessness and involuntary movements of all limbs. He had been prescribed ciprofloxacin 500 mg twice daily for a lower respiratory tract infection 7 days previously. He had generalised choreoathetosis affecting both upper and lower limbs. The temporal relationship with drug exposure and a dose which was on the upper limit for his renal impairment implicated ciprofloxacin as the culprit. His symptoms completely resolved within 1 week of drug withdrawal and never recurred subsequently.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23605987      PMCID: PMC3645130          DOI: 10.1136/bcr-2013-009293

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Case report: severe neurologic reaction to ciprofloxacin.

Authors:  W MacLeod
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

2.  Ciprofloxacin-induced chorea.

Authors:  Susan Azar; Amisha Ramjiani; Jay A Van Gerpen
Journal:  Mov Disord       Date:  2005-04       Impact factor: 10.338

3.  Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.

Authors:  I Tamai; J Yamashita; Y Kido; A Ohnari; Y Sai; Y Shima; K Naruhashi; S Koizumi; A Tsuji
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

4.  Reversible oral-facial dyskinesia in a patient receiving ciprofloxacin hydrochloride.

Authors:  P Pastor; E Moitinho; I Elizalde; I Cirera; E Tolosa
Journal:  J Neurol       Date:  1996-08       Impact factor: 4.849

5.  Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis.

Authors:  J Lipman; A Allworth; S C Wallis
Journal:  Clin Infect Dis       Date:  2000-11-07       Impact factor: 9.079

6.  Propriospinal myoclonus after treatment with ciprofloxacin.

Authors:  Bart Post; Johannes H T M Koelman; Marina A J Tijssen
Journal:  Mov Disord       Date:  2004-05       Impact factor: 10.338

7.  Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.

Authors:  E Singlas; A M Taburet; I Landru; H Albin; J P Ryckelinck
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  Potential neurologic toxicity related to ciprofloxacin.

Authors:  M T Schwartz; J F Calvert
Journal:  DICP       Date:  1990-02

9.  A new approach for early assessment of the epileptogenic potential of quinolones.

Authors:  A Delon; C Pariat; P Courtois; S Bouquet; W Couet
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  9 in total
  1 in total

1.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.